Related references
Note: Only part of the references are listed.Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
Virendra Singh et al.
JOURNAL OF HEPATOLOGY (2012)
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
Virendra Singh et al.
JOURNAL OF HEPATOLOGY (2012)
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
Thomas D. Boyer et al.
JOURNAL OF HEPATOLOGY (2011)
Predictors of Response to Therapy with Terlipressin and Albumin in Patients with Cirrhosis and Type 1 Hepatorenal Syndrome
Andre Nazar et al.
HEPATOLOGY (2010)
Systematic Review of Randomized Trials on Vasoconstrictor Drugs for Hepatorenal Syndrome
Lise L. Gluud et al.
HEPATOLOGY (2010)
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
Jean-Marie Trawale et al.
LIVER INTERNATIONAL (2010)
Combination Treatment With Octreotide, Midodrine, and Albumin Improves Survival in Patients With Type 1 and Type 2 Hepatorenal Syndrome
Catherine Skagen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
MEDICAL PROGRESS Renal Failure in Cirrhosis
Pere Gines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Midodrine Versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: A randomized pilot study
Virendra Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
An open label, pilot, randomized controlled trial of noradrenaline Versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response
Praveen Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome:: A randomized study
Marta Martin-Llahi et al.
GASTROENTEROLOGY (2008)
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome
Arun J. Sanyal et al.
GASTROENTEROLOGY (2008)
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome
Sergio Neri et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
C. Alessandria et al.
JOURNAL OF HEPATOLOGY (2007)
Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites
Georgios Kalambokis et al.
JOURNAL OF HEPATOLOGY (2007)
Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study
V Singh et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: A randomized study
V Singh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Patients with acute on chronic liver failure display 'sepsis-like' immune paralysis
HE Wasmuth et al.
JOURNAL OF HEPATOLOGY (2005)
Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
G Pomier-Layrargues et al.
HEPATOLOGY (2003)
Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2
C Alessandria et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Terlipressin therapy with and without albumin for patients with Hepatorenal syndrome:: Results of a prospective, nonrandomized study
R Ortega et al.
HEPATOLOGY (2002)
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome:: A pilot study
C Duvoux et al.
HEPATOLOGY (2002)
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study
R Moreau et al.
GASTROENTEROLOGY (2002)
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study
R Moreau et al.
GUT (2002)
New challenge of hepatorenal syndrome: Prevention and treatment
F Wong et al.
HEPATOLOGY (2001)
Terlipressin plus albumin infusion:: an effective and safe therapy of hepatorenal syndrome
J Uriz et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
